Through two completed Healthspan clinical trials, ARRA demonstrated that chronic, age-related diseases can be reversed — without pharmaceuticals. Help us reach more conditions and more lives.
See Our Proven ResultsFacility space, medical equipment, and lab supplies — all gratefully accepted to expand our research.
ARRA founder and director Clifton Huge has 30 days to raise $5 million to purchase the facility where all of ARRA's groundbreaking clinical research takes place. Without it, everything — the trials, the technology, the team — has to start over.
This is not a setback. This is an acquisition opportunity. The facility that has already reversed Type 2 Diabetes and dementia can be owned outright — securing ARRA's research future permanently and creating a tangible asset for investors.
Pitch deck and full financial prospectus available upon request
Our team completed two separate Healthspan clinical trials. The outcomes speak for themselves — and they redefined what is possible without a single pharmaceutical drug.
Our Healthspan trial protocols — combining precision nutrition, metabolic reprogramming, and regenerative interventions — demonstrated measurable reversal of Type 2 Diabetes markers in trial participants. No insulin. No metformin. No drugs.
Through integrated neurological protocols — including multibaric oxygen therapy, targeted biomarker interventions, and lifestyle precision medicine — our trials produced documented reversal of dementia symptoms and cognitive decline in participants.
Beyond Type 2 Diabetes and dementia, the Healthspan trials produced meaningful reversal outcomes across a range of age-related conditions — validating our core hypothesis: that the human body, given the right environment and interventions, can restore itself. The path forward is more research, more trials, and more reach.
These results are only the beginning. The next phase of research needs your support.
Help Fund What's NextThe conventional medical model reaches for a prescription. We reach deeper — into the body's own regenerative capacity, metabolic systems, and biological intelligence.
ARRA research focuses exclusively on interventions that treat, halt, or reverse disease through non-pharmaceutical means: regenerative medicine, precision nutrition, oxygen therapy, biomarker-guided protocols, lifestyle medicine, and advanced diagnostics.
Our clinical trials are designed to produce replicable, scalable therapies — so that discoveries made in the lab become accessible to veterans, first responders, tribal communities, and underserved populations who deserve the same access to breakthrough medicine as anyone else.
We've already proven it works. What we need now is the funding to reach more people, conduct more trials, and turn proven results into standard-of-care alternatives for millions.
ARRA Institute is a 501(c)(3) nonprofit. All donations are tax-deductible.
Facility space, medical equipment, lab supplies, and technology donations all directly accelerate our clinical research.
Building on our proven Healthspan results, we are now designing the next generation of trials — each targeting a specific disease using non-pharmaceutical, regenerative, and precision medicine approaches. You can fund a trial or register your interest as a future research participant.
Expanding our proven Healthspan protocol into a formal Phase I trial — integrating regenerative therapies, AI-guided biomarker tracking, precision nutrition, and oxygen protocols to extend the years of life lived in full vitality. No pharmaceutical interventions.
Investigating non-pharmaceutical approaches to autoimmune beta cell restoration — including stem cell-derived islet therapies, immunomodulation, and regenerative protocols — to halt progression and restore natural insulin production. Building on our Type 2 reversal results.
Extending our dementia reversal findings into a targeted Alzheimer's trial — exploring multibaric oxygen therapy, exosome therapy, neuro-regenerative protocols, and precision biomarker interventions to slow, halt, or reverse cognitive decline in early-to-moderate stages.
The following trials are in active development. You can fund the research now or register your interest to be notified when enrollment opens.
Facioscapulohumeral Muscular Dystrophy — investigating gene-adjacent regenerative protocols and targeted muscle restoration therapies to slow degeneration and restore function.
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome — exploring immune modulation, mitochondrial restoration, and oxygen-based regenerative therapies to address post-viral and systemic chronic fatigue without pharmaceutical dependency.
A comprehensive research program investigating regenerative and immunomodulatory approaches for a cluster of neurological autoimmune conditions — with the goal of halting immune attack and restoring nervous system function using non-pharmaceutical interventions.
After losing both my father and my brother to preventable diseases, I became deeply committed to transforming the way healthcare approaches prevention, healing, and longevity. Their passing was not only personal — it was a powerful reminder that too many lives are lost to conditions that could be prevented, better managed, or even reversed with earlier intervention and access to advanced care.
Our mission is to establish a charitable healthcare organization dedicated to healing, preventing, and reversing disease through cutting-edge science and technology — specifically through non-pharmaceutical interventions. We integrate advanced diagnostics, precision medicine, regenerative therapies, longevity protocols, and evidence-based wellness strategies to optimize healthspan and lifespan.
A core pillar of our mission is service to veterans, first responders, tribal communities, and underserved populations who often lack access to advanced therapeutic modalities. Through fundraising, strategic partnerships, and community outreach, we expand access to breakthrough treatments and preventative healthcare solutions for those who need them most.
We are building a sustainable, forward-thinking healthcare model that:
By combining innovation, compassion, and accessibility, we aim to create a system that not only extends life — but transforms its quality.
Regenerative therapies for those who gave their health in service. Our protocols address TBI, PTSD-related physical effects, chronic pain, and accelerated aging.
Healing the healers and defenders who face physical and psychological burdens that accumulate silently over careers of service.
Bringing advanced non-pharmaceutical care to Native and Indigenous communities historically excluded from medical innovation and clinical research.
Expanding equitable access to breakthrough medicine regardless of geography, income, or background — because healing shouldn't be a privilege.
We've reversed Type 2 Diabetes. We've reversed dementia. We did it without pharmaceuticals. The next chapter of this research needs your support — and the people who benefit need your compassion.